Pedro Ballester

Dr. Pedro Ballester

Cancer Research Center of Marseille, INSERM U1068, F-13009 Marseille, France
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2010 in Bioinformatics
Verified
Journal Article
Open access
PDF file
Pedro BallesterPedro Ballester
Pedro Ballester
JMJohn Mitchell
John Mitchell
Motivation: Accurately predicting the binding affinities of large sets of diverse protein–ligand complexes is an extremely challenging task. The scoring functions that attempt such computational prediction are essential for analysing the outputs of molecular docking, which in turn is an important technique for drug discovery, chemical biology and structural biology. Each scoring function assumes a predetermined theory-inspired functional form for the relationship between the variables that characterize the complex, which also include parameters fitted to experimental or simulation data and its predicted binding affinity. The inherent problem of this rigid approach is that it leads to poor predictivity for those complexes that do not conform to the modelling assumptions. Moreover, resampling strategies, such as cross-validation or bootstrapping, are still not systematically used to guard against the overfitting of calibration data in parameter estimation for scoring functions. Results: We propose a novel scoring function (RF-Score) that circumvents the need for problematic modelling assumptions via non-parametric machine learning. In particular, Random Forest was used to implicitly capture binding effects that are hard to model explicitly. RF-Score is compared with the state of the art on the demanding PDBbind benchmark. Results show that RF-Score is a very competitive scoring function. Importantly, RF-Score's performance was shown to improve dramatically with training set size and hence the future availability of more high-quality structural and interaction data is expected to lead to improved versions of RF-Score. Contact:pedro.ballester@ebi.ac.uk; jbom@st-andrews.ac.uk Supplementary information: Supplementary data are available at Bioinformatics online.

30 April 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MMMichael P. Menden
Michael P. Menden
Francesco IorioFrancesco Iorio
Francesco Iorio
MGMathew Garnett
Mathew Garnett
UMUltan McDermott
Ultan McDermott
CBCyril H. Benes
Cyril H. Benes
JSJulio Saez-Rodriguez
Julio Saez-Rodriguez
Predicting the response of a specific cancer to a therapy is a major goal in modern oncology that should ultimately lead to a personalised treatment. High-throughput screenings of potentially active compounds against a panel of genomically heterogeneous cancer cell lines have unveiled multiple relationships between genomic alterations and drug responses. Various computational approaches have been proposed to predict sensitivity based on genomic features, while others have used the chemical properties of the drugs to ascertain their effect. In an effort to integrate these complementary approaches, we developed machine learning models to predict the response of cancer cell lines to drug treatment, quantified through IC 50 values, based on both the genomic features of the cell lines and the chemical properties of the considered drugs. Models predicted IC 50 values in a 8-fold cross-validation and an independent blind test with coefficient of determination R 2 of 0.72 and 0.64 respectively. Furthermore, models were able to predict with comparable accuracy (R 2 of 0.61) IC50s of cell lines from a tissue not used in the training stage. Our in silico models can be used to optimise the experimental design of drug-cell screenings by estimating a large proportion of missing IC 50 values rather than experimentally measuring them. The implications of our results go beyond virtual drug screening design: potentially thousands of drugs could be probed in silico to systematically test their potential efficacy as anti-tumour agents based on their structure, thus providing a computational framework to identify new drug repositioning opportunities as well as ultimately be useful for personalized medicine by linking the genomic traits of patients to drug sensitivity.

25 April 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MWMaciej Wójcikowski
Maciej Wójcikowski
Pedro BallesterPedro Ballester
Pedro Ballester
PSPaweł Siedlecki
Paweł Siedlecki
Classical scoring functions have reached a plateau in their performance in virtual screening and binding affinity prediction. Recently, machine-learning scoring functions trained on protein-ligand complexes have shown great promise in small tailored studies. They have also raised controversy, specifically concerning model overfitting and applicability to novel targets. Here we provide a new ready-to-use scoring function (RF-Score-VS) trained on 15 426 active and 893 897 inactive molecules docked to a set of 102 targets. We use the full DUD-E data sets along with three docking tools, five classical and three machine-learning scoring functions for model building and performance assessment. Our results show RF-Score-VS can substantially improve virtual screening performance: RF-Score-VS top 1% provides 55.6% hit rate, whereas that of Vina only 16.2% (for smaller percent the difference is even more encouraging: RF-Score-VS top 0.1% achieves 88.6% hit rate for 27.5% using Vina). In addition, RF-Score-VS provides much better prediction of measured binding affinity than Vina (Pearson correlation of 0.56 and −0.18, respectively). Lastly, we test RF-Score-VS on an independent test set from the DEKOIS benchmark and observed comparable results. We provide full data sets to facilitate further research in this area (http://github.com/oddt/rfscorevs) as well as ready-to-use RF-Score-VS (http://github.com/oddt/rfscorevs_binary).

28 August 2015 in WIREs Computational Molecular Science
Verified
Journal Article
Open access
PDF file
QAQurrat Ul Ain
Qurrat Ul Ain
AAAntoniya Aleksandrova
Antoniya Aleksandrova
FRFlorian D. Roessler
Florian D. Roessler
Pedro BallesterPedro Ballester
Pedro Ballester
Docking tools to predict whether and how a small molecule binds to a target can be applied if a structural model of such target is available. The reliability of docking depends, however, on the accuracy of the adopted scoring function (SF). Despite intense research over the years, improving the accuracy of SFs for structure‐based binding affinity prediction or virtual screening has proven to be a challenging task for any class of method. New SFs based on modern machine‐learning regression models, which do not impose a predetermined functional form and thus are able to exploit effectively much larger amounts of experimental data, have recently been introduced. These machine‐learning SFs have been shown to outperform a wide range of classical SFs at both binding affinity prediction and virtual screening. The emerging picture from these studies is that the classical approach of using linear regression with a small number of expert‐selected structural features can be strongly improved by a machine‐learning approach based on nonlinear regression allied with comprehensive data‐driven feature selection. Furthermore, the performance of classical SFs does not grow with larger training datasets and hence this performance gap is expected to widen as more training data becomes available in the future. Other topics covered in this review include predicting the reliability of a SF on a particular target class, generating synthetic data to improve predictive performance and modeling guidelines for SF development. WIREs Comput Mol Sci 2015, 5:405–424. doi: 10.1002/wcms.1225This article is categorized under: Computer and Information Science > Chemoinformatics

6 March 2007 in Journal of Computational Chemistry
Verified
Journal Article
Closed access
PDF file
Pedro BallesterPedro Ballester
Pedro Ballester
WRW. Graham Richards
W. Graham Richards

12 February 2015 in Molecular Informatics
Verified
Journal Article
Closed access
PDF file
HLHongjian Li
Hongjian Li
KLKwong‐Sak Leung
Kwong‐Sak Leung
MWMan‐Hon Wong
Man‐Hon Wong
Pedro BallesterPedro Ballester
Pedro Ballester